Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chondrogenitor cells and gene therapy.

J U Yoo1, I Mandell, P Angele

  • 1Department of Orthopaedics, Case Western Reserve University, Cleveland, OH, USA.

Clinical Orthopaedics and Related Research
|October 20, 2000
PubMed
Summary

Mesenchymal progenitor cells show promise for musculoskeletal tissue repair. Gene therapy techniques, particularly ex vivo gene transfer, maintain their chondrogenic potential for effective cartilage regeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of temporomandibular joint articular disc progenitor cell clones.

European cells & materials·2023
Same author

Sandwich Technique for Large Osteochondral Lesions of the Knee.

Cartilage·2022
Same author

Cell-based regenerative joint therapy: a hot topic.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2022
Same author

Long term outcomes of biomaterial-mediated repair of focal cartilage defects in a large animal model.

European cells & materials·2021
Same author

Platelet-rich plasma (PRP) as therapy for cartilage, tendon and muscle damage - German working group position statement.

Journal of experimental orthopaedics·2020
Same author

Cells under pressure - the relationship between hydrostatic pressure and mesenchymal stem cell chondrogenesis.

European cells & materials·2019

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cell Biology

Background:

  • Mesenchymal progenitor cells (MPCs) are crucial for musculoskeletal tissue repair and regeneration.
  • Chondrogenic differentiation of MPCs is influenced by cytokines, notably the transforming growth factor-beta superfamily.
  • Current cartilage repair strategies involve cytokine or cell delivery, with gene therapy emerging as a novel approach.

Purpose of the Study:

  • To explore the application of gene transfer techniques for enhancing musculoskeletal tissue repair using mesenchymal progenitor cells.
  • To investigate the potential of ex vivo gene therapy for delivering chondroinductive factors to damaged cartilage sites.
  • To assess the maintenance of chondrogenic potential in MPCs following virally mediated ex vivo gene transfer.

Main Methods:

Related Experiment Videos

  • Isolation and culture of mesenchymal progenitor cells from various tissues.
  • Application of gene transfer techniques, including viral and nonviral vectors for in vivo and ex vivo gene therapy.
  • Evaluation of chondrogenic differentiation potential of genetically modified MPCs in vitro.

Main Results:

  • Ex vivo gene transfer using viral vectors maintains the chondrogenic potential of mesenchymal progenitor cells.
  • Transducing MPCs with chondroinductive factors facilitates targeted delivery of bioactive factors to repair sites.
  • Gene-modified MPCs offer a promising strategy for in situ cartilage regeneration.

Conclusions:

  • Ex vivo gene therapy represents a viable strategy for enhancing the regenerative capacity of mesenchymal progenitor cells for cartilage repair.
  • The targeted delivery of chondroinductive factors via gene-modified MPCs holds significant potential for musculoskeletal tissue regeneration.
  • Further research into in vivo applications and long-term efficacy is warranted.